Soligenix

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Soligenix and other ETFs, options, and stocks.

About SNGX

Soligenix, Inc. is a late-stage biopharmaceutical company, which engages in the development and commercialization of products to treat rare diseases. It operates through the Specialized BioTherapeutics and Public Health Solutions segments. 

CEO
Christopher J. Schaber
CEOChristopher J. Schaber
Employees
15
Employees15
Headquarters
Princeton, New Jersey
HeadquartersPrinceton, New Jersey
Founded
1987
Founded1987
Employees
15
Employees15

SNGX Key Statistics

Market cap
4.33M
Market cap4.33M
Price-Earnings ratio
-0.44
Price-Earnings ratio-0.44
Dividend yield
Dividend yield
Average volume
15.91M
Average volume15.91M
High today
$0.40
High today$0.40
Low today
$0.3936
Low today$0.3936
Open price
$0.41
Open price$0.41
Volume
18.86K
Volume18.86K
52 Week high
$4.20
52 Week high$4.20
52 Week low
$0.3705
52 Week low$0.3705

SNGX News

TipRanks 5d
Soligenix prices $4.75M public offering at 40c per share

Soligenix “announced the pricing of its public offering of 11,875,000 shares of common stock and warrants to purchase up to 11,875,000 shares of common stock at...

Benzinga 7d
SNGX: Agreement with EMA on Second Confirmatory Trial for HyBryte™ - Soligenix - Benzinga

Loading... Loading... By David Bautz, PhD Business Update Reaches Agreement with European Medicines Agency on Second Confirmatory Trial for HyBryte™ On Apri...

SNGX: Agreement with EMA on Second Confirmatory Trial for HyBryte™ - Soligenix - Benzinga
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.